Secretaría de Gobernación
CONACYT
INGER
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17285
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by-nc/4.0es_MX
dc.creatorMARIO ULISES PEREZ ZEPEDAes_MX
dc.creatorLUIS MIGUEL FRANCISCO GUTIERREZ ROBLEDOes_MX
dc.creatorVICTORIA EUGENIA ARANGO LOPERAes_MX
dc.date2013-
dc.date.accessioned2021-10-28T17:38:52Z-
dc.date.available2021-10-28T17:38:52Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17285-
dc.descriptionDear Editor, Regarding the recent report by Patil and colleagues about sarcopenia and osteopenia prevalence [1], we would like to address some methodological issues. It is stated that the prevalence of sarcopenia using the European Working Group on Sarcopenia in Older People (EWGSOP) is 0.9 %. This is grossly out of other frequencies reported using the same algorithm, which is over 30 %. The first report by Landi and colleagues showed a prevalence of 32.8 % in a group of institutionalized elderly (n = 122), while our group reported 33.6 % in an ambulatory sample of 70 years or older subjects (n = 345) [2, 3]. The first report included all the residents of the nursing home where the study was performed, while our study used a representative sample of Mexico City. However, the sample of Patil et al. was derived from an intervention study, in which neither the whole population (n = 9,370) nor a representative sample was used. Although an excellent sample of a study was aimed to have internal validity, external validity represented by prevalence could be misleading [4]. Nevertheless, other factors could contribute to different frequencies of sarcopenia, like those already pointed by the authors: lack of precise diagnostic criteria and unavailability of standard reference data to the components of the EWGSOP algorithm [1, 5].es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherSpringer, National Osteoporosis Foundation, USA & International Osteoporosis Foundationes_MX
dc.relationhttps://link.springer.com/article/10.1007/s00198-012-2091-xes_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceOsteoporosis International (1433-2965) Vol. 24 (2013)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectEnfermedades óseas metabólicases_MX
dc.subjectOsteopeniaes_MX
dc.subjectAtrofia musculares_MX
dc.subjectSarcopeniaes_MX
dc.subjectGeriatricses_MX
dc.subjectBone diseases, metabolices_MX
dc.subjectMuscular atrophyes_MX
dc.titleSarcopenia prevalencees_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idPEZM760111HDFRPR07es_MX
dc.creator.idGURL571005HDFTBS14es_MX
dc.creator.idAALV680413MNERPC04es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Osteoporosis International (1433-2965) Vol. 24 (2013).pdf52.14 kBAdobe PDFVisualizar/Abrir